25 XP   0   0   10

Eton Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Eton Pharmaceuticals Inc together

PenkeI guess you are interested in Eton Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Eton Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Eton Pharmaceuticals Inc

I send you an email if I find something interesting about Eton Pharmaceuticals Inc.

Quick analysis of Eton Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Eton Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
12.0%

What is your share worth?

Current worth
$0.60
Expected worth in 1 year
$0.70
How sure are you?
36.0%

+ What do you gain per year?

Total Gains per Share
$0.09
Return On Investment
2.8%

For what price can you sell your share?

Current Price per Share
$3.28
Expected price per share
$2.3601 - $3.97
How sure are you?
50%

1. Valuation of Eton Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$3.28

Intrinsic Value Per Share

$12.39 - $14.93

Total Value Per Share

$13.00 - $15.54

2. Growth of Eton Pharmaceuticals Inc (5 min.)




Is Eton Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$15.4m$12.7m$2.3m15.7%

How much money is Eton Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$297k-$2.4m$2.1m710.8%
Net Profit Margin-14.0%-92.2%--

How much money comes from the company's main activities?

3. Financial Health of Eton Pharmaceuticals Inc (5 min.)




What can you expect buying and holding a share of Eton Pharmaceuticals Inc? (5 min.)

Welcome investor! Eton Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Eton Pharmaceuticals Inc.

What can you expect buying and holding a share of Eton Pharmaceuticals Inc?

First you should know what it really means to hold a share of Eton Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Eton Pharmaceuticals Inc is $3.28. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Eton Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Eton Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.60. Based on the TTM, the Book Value Change Per Share is $0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Eton Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.09-2.7%-0.01-0.3%-0.09-2.7%-0.11-3.5%-0.16-5.0%
Usd Book Value Change Per Share-0.05-1.7%0.020.7%-0.04-1.3%-0.02-0.6%0.020.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.1%0.000.1%
Usd Total Gains Per Share-0.05-1.7%0.020.7%-0.04-1.3%-0.02-0.6%0.030.9%
Usd Price Per Share4.38-3.97-2.98-5.28-4.47-
Price to Earnings Ratio-12.47--15.77--0.16--6.26--5.07-
Price-to-Total Gains Ratio-80.67-50.17--123.21--18.25--17.05-
Price to Book Ratio7.27-6.96-5.95-16.29-13.27-
Price-to-Total Gains Ratio-80.67-50.17--123.21--18.25--17.05-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.28
Number of shares304
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.02-0.02
Usd Total Gains Per Share0.02-0.02
Gains per Quarter (304 shares)7.10-5.55
Gains per Year (304 shares)28.41-22.19
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1028183-26-32
2057467-51-54
30857410-77-76
4011410214-102-98
5014213017-128-120
6017015821-154-142
7019918624-179-164
8022721427-205-186
9025624231-231-208
10028427034-256-230

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%4.08.00.033.3%4.016.00.020.0%4.021.00.016.0%4.021.00.016.0%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%7.013.00.035.0%9.016.00.036.0%9.016.00.036.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%2.00.018.010.0%3.00.022.012.0%3.00.022.012.0%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%7.013.00.035.0%9.016.00.036.0%9.016.00.036.0%

Fundamentals of Eton Pharmaceuticals Inc

About Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Fundamental data was last updated by Penke on 2024-04-11 07:11:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Eton Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Eton Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -30.8% means that $-0.31 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Eton Pharmaceuticals Inc:

  • The MRQ is -30.8%. The company is making a huge loss. -2
  • The TTM is -14.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-30.8%TTM-14.0%-16.9%
TTM-14.0%YOY-92.2%+78.2%
TTM-14.0%5Y-2,076.3%+2,062.3%
5Y-2,076.3%10Y-1,661.1%-415.3%
1.1.2. Return on Assets

Shows how efficient Eton Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -7.1% Return on Assets means that Eton Pharmaceuticals Inc generated $-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Eton Pharmaceuticals Inc:

  • The MRQ is -7.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.1%TTM-1.6%-5.5%
TTM-1.6%YOY-10.7%+9.1%
TTM-1.6%5Y-16.6%+15.0%
5Y-16.6%10Y-20.0%+3.4%
1.1.3. Return on Equity

Shows how efficient Eton Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -14.6% Return on Equity means Eton Pharmaceuticals Inc generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Eton Pharmaceuticals Inc:

  • The MRQ is -14.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.6%TTM-4.2%-10.4%
TTM-4.2%YOY-19.2%+15.0%
TTM-4.2%5Y-45.3%+41.1%
5Y-45.3%10Y-44.7%-0.6%

1.2. Operating Efficiency of Eton Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Eton Pharmaceuticals Inc is operating .

  • Measures how much profit Eton Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Eton Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-4.6%+4.6%
TTM-4.6%YOY-83.1%+78.5%
TTM-4.6%5Y-2,019.0%+2,014.4%
5Y-2,019.0%10Y-1,615.2%-403.8%
1.2.2. Operating Ratio

Measures how efficient Eton Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.78 means that the operating costs are $1.78 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 1.776. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.252. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.776TTM1.252+0.524
TTM1.252YOY1.824-0.572
TTM1.2525Y20.915-19.663
5Y20.91510Y16.732+4.183

1.3. Liquidity of Eton Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Eton Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.65 means the company has $1.65 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 1.653. The company is able to pay all its short-term debts. +1
  • The TTM is 2.391. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.653TTM2.391-0.738
TTM2.391YOY4.298-1.907
TTM2.3915Y5.662-3.272
5Y5.66210Y6.774-1.112
1.3.2. Quick Ratio

Measures if Eton Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.21 means the company can pay off $0.21 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 0.210. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.897. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.210TTM1.897-1.687
TTM1.897YOY3.824-1.927
TTM1.8975Y4.915-3.018
5Y4.91510Y5.470-0.555

1.4. Solvency of Eton Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Eton Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Eton Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.51 means that Eton Pharmaceuticals Inc assets are financed with 51.2% credit (debt) and the remaining percentage (100% - 51.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 0.512. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.492. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.512TTM0.492+0.021
TTM0.492YOY0.452+0.040
TTM0.4925Y0.403+0.089
5Y0.40310Y0.358+0.045
1.4.2. Debt to Equity Ratio

Measures if Eton Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 105.1% means that company has $1.05 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Eton Pharmaceuticals Inc:

  • The MRQ is 1.051. The company is able to pay all its debts with equity. +1
  • The TTM is 0.974. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.051TTM0.974+0.077
TTM0.974YOY0.828+0.146
TTM0.9745Y0.997-0.023
5Y0.99710Y0.846+0.151

2. Market Valuation of Eton Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Eton Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Eton Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -12.47 means the investor is paying $-12.47 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Eton Pharmaceuticals Inc:

  • The EOD is -9.337. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.468. Based on the earnings, the company is expensive. -2
  • The TTM is -15.775. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.337MRQ-12.468+3.131
MRQ-12.468TTM-15.775+3.306
TTM-15.775YOY-0.156-15.619
TTM-15.7755Y-6.257-9.518
5Y-6.25710Y-5.066-1.191
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Eton Pharmaceuticals Inc:

  • The EOD is -54.289. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -72.496. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -13.641. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-54.289MRQ-72.496+18.207
MRQ-72.496TTM-13.641-58.855
TTM-13.641YOY8.960-22.601
TTM-13.6415Y-9.976-3.665
5Y-9.97610Y-8.841-1.135
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Eton Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Eton Pharmaceuticals Inc:

  • The EOD is 5.444. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.270. Based on the equity, the company is overpriced. -1
  • The TTM is 6.960. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.444MRQ7.270-1.826
MRQ7.270TTM6.960+0.310
TTM6.960YOY5.954+1.006
TTM6.9605Y16.288-9.329
5Y16.28810Y13.270+3.019
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Eton Pharmaceuticals Inc.

3.1. Institutions holding Eton Pharmaceuticals Inc

Institutions are holding 27.892% of the shares of Eton Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Opaleye Management Inc9.85992.94652529887996174.099
2023-12-31Vanguard Group Inc4.00530.00011027688512525.2489
2023-12-31Westside Investment Management, Inc.2.19460.6306563110348006.587
2023-12-31Acuitas Investments, LLC1.91771.1254492054273054124.6822
2023-12-31Paradigm Capital Management, Inc.1.16920.068330000000
2023-12-31BlackRock Inc1.10780284241-935-0.3279
2023-12-31Bridgeway Capital Management, LLC0.98740.0238253362-18100-6.6676
2023-12-31Geode Capital Management, LLC0.88570.000122725696274.4236
2023-12-31Parkman Healthcare Partners LLC0.77620.12291991683416820.7079
2023-12-31Ameriprise Financial Inc0.63110.0002161928-24634-13.2042
2023-12-31Acadian Asset Management LLC0.53580.00231374884022441.3555
2023-12-31State Street Corporation0.317308140300
2023-12-31Bank of New York Mellon Corp0.30950.00017940200
2023-12-31Essex Investment Management Company, LLC0.30640.067878613-31403-28.544
2023-09-30JANE STREET GROUP, LLC0.25410.000165210652100
2023-12-31Northern Trust Corp0.25170.0001645902708372.2079
2023-12-31Squarepoint Ops LLC0.24720.0005634241878242.0725
2023-12-31Two Sigma Investments LLC0.20460.000552500-27052-34.0054
2023-12-31Qube Research & Technologies0.19660.00045044345686960.3952
2023-09-30Schonfeld Strategic Advisors LLC0.16990.001443600436000
Total 26.3284.99116755367+640979+9.5%

3.2. Funds holding Eton Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.65380.000268171700
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.19740.001330758000
2024-03-31Paradigm Micro-Cap1.16790.681830000000
2023-12-31Bridgeway Ultra-Small Company0.74180.96319056200
2024-02-29Fidelity Extended Market Index0.48590.0015124829-605-0.4823
2024-02-29Vifag 2002 SICAV0.35040.6269000000
2023-12-31Bridgeway Ultra-Small Company Market0.21760.131855900-25000-30.9023
2024-03-28iShares Micro-Cap ETF0.17090.01794391100
2024-02-29Fidelity Total Market Index0.14830.00023808400
2023-09-30BlackRock Extended Mkt Composite0.14180.00113643100
2024-03-31BlackRock Extended Equity Market K0.12380.000831794110.0346
2024-02-29Fidelity Series Total Market Index0.11750.00023017300
2023-12-31Bailard Micrcap Value0.08810.376322639226390
2024-02-29Nationwide Bailard Cogntv Val M0.08810.10112263900
2023-12-31Bailard Small Cap Value0.08810.098122639226390
2023-12-31Northern Trust Extended Eq Market Idx0.07810.001520073265315.2296
2023-12-31NT Ext Equity Mkt Idx Fd - L0.07810.001520073265315.2296
2024-02-29Fidelity Nasdaq Composite Index0.07540.00061937100
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.07150.00131835900
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.06030.00021550000
Total 8.14483.00642092274+24990+1.2%

3.3. Insider Transactions

Insiders are holding 12.969% of the shares of Eton Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-09-22Sean BrynjelsenBUY100002.1
2021-11-17Opaleye Management Inc.SELL250004.67
2021-11-15Opaleye Management Inc.SELL30004.8
2021-11-08Opaleye Management Inc.SELL526616.1
2021-11-05Opaleye Management Inc.SELL1677016.3
2021-11-03Opaleye Management Inc.SELL1165006.53
2021-10-11Opaleye Management Inc.SELL341015.01
2021-10-08Opaleye Management Inc.SELL436925
2021-08-06Opaleye Management Inc.SELL3450005.84
2021-08-04Opaleye Management Inc.SELL1040005.75
2021-06-03Sean BrynjelsenBUY50005.96
2021-05-27Opaleye Management Inc.SELL1260008.49
2021-05-25Opaleye Management Inc.SELL480008.53
2021-04-12Harrow Health, Inc.SELL15180007

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Eton Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0540.023-332%-0.043-22%-0.021-61%0.024-325%
Book Value Per Share--0.6020.585+3%0.495+22%0.544+11%0.530+14%
Current Ratio--1.6532.391-31%4.298-62%5.662-71%6.774-76%
Debt To Asset Ratio--0.5120.492+4%0.452+13%0.403+27%0.358+43%
Debt To Equity Ratio--1.0510.974+8%0.828+27%0.997+5%0.846+24%
Dividend Per Share----0%-0%0.003-100%0.004-100%
Eps---0.088-0.010-89%-0.0880%-0.114+29%-0.164+86%
Free Cash Flow Per Share---0.0150.058-126%0.020-176%-0.082+445%-0.090+497%
Free Cash Flow To Equity Per Share---0.0270.049-155%0.018-244%-0.012-55%0.145-118%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--14.935--------
Intrinsic Value_10Y_min--12.395--------
Intrinsic Value_1Y_max--0.217--------
Intrinsic Value_1Y_min--0.212--------
Intrinsic Value_3Y_max--1.626--------
Intrinsic Value_3Y_min--1.533--------
Intrinsic Value_5Y_max--4.212--------
Intrinsic Value_5Y_min--3.826--------
Market Cap84256968.000-34%112513878.000102335490.750+10%76424142.000+47%136063516.050-17%115139259.720-2%
Net Profit Margin---0.308-0.140-55%-0.922+199%-20.763+6631%-16.611+5285%
Operating Margin----0.0460%-0.8310%-20.1900%-16.1520%
Operating Ratio--1.7761.252+42%1.824-3%20.915-92%16.732-89%
Pb Ratio5.444-34%7.2706.960+4%5.954+22%16.288-55%13.270-45%
Pe Ratio-9.337+25%-12.468-15.775+27%-0.156-99%-6.257-50%-5.066-59%
Price Per Share3.280-34%4.3803.973+10%2.975+47%5.280-17%4.469-2%
Price To Free Cash Flow Ratio-54.289+25%-72.496-13.641-81%8.960-909%-9.976-86%-8.841-88%
Price To Total Gains Ratio-60.412+25%-80.67250.172-261%-123.210+53%-18.249-77%-17.049-79%
Quick Ratio--0.2101.897-89%3.824-95%4.915-96%5.470-96%
Return On Assets---0.071-0.016-78%-0.107+51%-0.166+134%-0.200+182%
Return On Equity---0.146-0.042-71%-0.192+31%-0.453+211%-0.447+207%
Total Gains Per Share---0.0540.023-332%-0.043-22%-0.018-66%0.028-294%
Usd Book Value--15477000.00015083750.000+3%12721000.000+22%14017050.000+10%13647320.000+13%
Usd Book Value Change Per Share---0.0540.023-332%-0.043-22%-0.021-61%0.024-325%
Usd Book Value Per Share--0.6020.585+3%0.495+22%0.544+11%0.530+14%
Usd Dividend Per Share----0%-0%0.003-100%0.004-100%
Usd Eps---0.088-0.010-89%-0.0880%-0.114+29%-0.164+86%
Usd Free Cash Flow---388000.0001510000.000-126%508250.000-176%-2108750.000+443%-2313120.000+496%
Usd Free Cash Flow Per Share---0.0150.058-126%0.020-176%-0.082+445%-0.090+497%
Usd Free Cash Flow To Equity Per Share---0.0270.049-155%0.018-244%-0.012-55%0.145-118%
Usd Market Cap84256968.000-34%112513878.000102335490.750+10%76424142.000+47%136063516.050-17%115139259.720-2%
Usd Price Per Share3.280-34%4.3803.973+10%2.975+47%5.280-17%4.469-2%
Usd Profit---2256000.000-297000.000-87%-2408000.000+7%-2953250.000+31%-3189480.000+41%
Usd Revenue--7313000.0007910500.000-8%5312750.000+38%3786150.000+93%3028920.000+141%
Usd Total Gains Per Share---0.0540.023-332%-0.043-22%-0.018-66%0.028-294%
 EOD+3 -5MRQTTM+7 -25YOY+15 -175Y+18 -1610Y+18 -16

4.2. Fundamental Score

Let's check the fundamental score of Eton Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.337
Price to Book Ratio (EOD)Between0-15.444
Net Profit Margin (MRQ)Greater than0-0.308
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.210
Current Ratio (MRQ)Greater than11.653
Debt to Asset Ratio (MRQ)Less than10.512
Debt to Equity Ratio (MRQ)Less than11.051
Return on Equity (MRQ)Greater than0.15-0.146
Return on Assets (MRQ)Greater than0.05-0.071
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Eton Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.644
Ma 20Greater thanMa 503.459
Ma 50Greater thanMa 1003.948
Ma 100Greater thanMa 2004.152
OpenGreater thanClose3.270
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Interest Income  -15024-1262-12493-31815784



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets31,740
Total Liabilities16,263
Total Stockholder Equity15,477
 As reported
Total Liabilities 16,263
Total Stockholder Equity+ 15,477
Total Assets = 31,740

Assets

Total Assets31,740
Total Current Assets26,839
Long-term Assets4,901
Total Current Assets
Cash And Cash Equivalents 21,388
Net Receivables 3,411
Inventory 911
Other Current Assets 1,129
Total Current Assets  (as reported)26,839
Total Current Assets  (calculated)26,839
+/-0
Long-term Assets
Property Plant Equipment 150
Long-term Assets Other 12
Long-term Assets  (as reported)4,901
Long-term Assets  (calculated)162
+/- 4,739

Liabilities & Shareholders' Equity

Total Current Liabilities16,241
Long-term Liabilities22
Total Stockholder Equity15,477
Total Current Liabilities
Short Long Term Debt 5,380
Accounts payable 1,848
Total Current Liabilities  (as reported)16,241
Total Current Liabilities  (calculated)7,228
+/- 9,013
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt22
Long-term Liabilities  (as reported)22
Long-term Liabilities  (calculated)22
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)15,477
Total Stockholder Equity (calculated)0
+/- 15,477
Other
Capital Stock26
Common Stock Shares Outstanding 25,658
Net Invested Capital 20,857
Net Working Capital 10,598
Property Plant and Equipment Gross 545



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
> Total Assets 
0
13,443
11,712
9,646
7,525
28,327
23,017
18,244
13,507
17,072
17,241
14,559
11,395
26,319
31,186
29,906
26,606
27,465
23,196
23,046
21,520
25,030
23,928
30,932
31,526
31,740
31,74031,52630,93223,92825,03021,52023,04623,19627,46526,60629,90631,18626,31911,39514,55917,24117,07213,50718,24423,01728,3277,5259,64611,71213,4430
   > Total Current Assets 
0
13,292
11,353
9,162
6,803
27,502
21,527
16,755
12,107
15,009
15,341
12,823
9,785
24,701
30,274
29,075
25,863
23,604
18,751
19,776
16,420
20,004
19,118
26,333
27,157
26,839
26,83927,15726,33319,11820,00416,42019,77618,75123,60425,86329,07530,27424,7019,78512,82315,34115,00912,10716,75521,52727,5026,8039,16211,35313,2920
       Cash And Cash Equivalents 
0
13,156
11,215
8,946
6,603
26,735
19,584
14,947
11,777
12,066
12,335
10,270
7,332
21,295
25,113
25,802
22,709
14,406
15,229
17,046
13,378
16,305
14,708
21,566
22,070
21,388
21,38822,07021,56614,70816,30513,37817,04615,22914,40622,70925,80225,11321,2957,33210,27012,33512,06611,77714,94719,58426,7356,6038,94611,21513,1560
       Net Receivables 
0
0
0
0
0
0
0
0
0
473
205
0
0
48
300
303
385
5,471
796
834
1,498
1,852
2,874
3,084
3,495
3,411
3,4113,4953,0842,8741,8521,4988347965,4713853033004800205473000000000
       Other Current Assets 
0
136
138
216
200
767
1,943
1,808
330
2,090
1,075
844
754
2,116
2,962
1,728
2,435
3,177
2,216
1,365
1,063
1,290
1,099
867
541
1,129
1,1295418671,0991,2901,0631,3652,2163,1772,4351,7282,9622,1167548441,0752,0903301,8081,9437672002161381360
   > Long-term Assets 
0
0
359
484
722
825
1,490
1,489
1,400
2,063
1,900
1,736
1,610
1,618
912
831
743
3,861
4,445
3,270
5,100
5,026
4,810
4,599
4,369
4,901
4,9014,3694,5994,8105,0265,1003,2704,4453,8617438319121,6181,6101,7361,9002,0631,4001,4891,49082572248435900
       Property Plant Equipment 
0
119
203
233
268
773
1,442
1,445
1,360
1,277
1,154
1,034
917
1,003
339
299
257
219
193
150
115
260
225
195
147
150
1501471952252601151501932192572993391,0039171,0341,1541,2771,3601,4451,4427732682332031190
       Intangible Assets 
0
0
0
0
0
0
0
0
0
725
688
650
612
575
537
500
463
3,621
4,240
3,108
4,973
4,754
4,573
4,392
4,210
0
04,2104,3924,5734,7544,9733,1084,2403,621463500537575612650688725000000000
       Other Assets 
0
32
156
251
454
52
48
44
40
61
58
52
81
232
36
32
23
21
12
12
12
12
0
12
0
0
0012012121212212332362328152586140444852454251156320
> Total Liabilities 
0
1,313
1,550
2,150
2,774
2,024
3,775
1,545
1,159
6,522
6,621
7,528
10,007
10,656
9,631
9,170
10,946
9,835
9,813
9,804
10,339
11,952
12,687
14,207
14,634
16,263
16,26314,63414,20712,68711,95210,3399,8049,8139,83510,9469,1709,63110,65610,0077,5286,6216,5221,1591,5453,7752,0242,7742,1501,5501,3130
   > Total Current Liabilities 
0
793
947
1,134
1,197
2,024
3,656
1,459
1,107
1,963
2,051
2,739
3,219
3,794
3,199
3,106
5,360
4,558
3,482
3,812
4,661
6,461
7,494
9,588
10,393
16,241
16,24110,3939,5887,4946,4614,6613,8123,4824,5585,3603,1063,1993,7943,2192,7392,0511,9631,1071,4593,6562,0241,1971,1349477930
       Short-term Debt 
0
0
0
0
0
0
123
0
0
0
0
159
219
280
726
749
1,092
1,418
0
364
708
1,033
1,339
1,540
1,540
0
01,5401,5401,3391,03370836401,4181,0927497262802191590000123000000
       Short Long Term Debt 
0
0
0
0
0
0
123
0
0
0
0
159
219
280
726
749
1,092
1,418
0
364
708
1,033
1,339
1,540
1,540
5,380
5,3801,5401,5401,3391,03370836401,4181,0927497262802191590000123000000
       Accounts payable 
0
539
801
868
793
1,421
3,208
883
549
575
1,183
1,953
2,208
2,344
1,761
1,522
3,273
1,774
2,131
1,299
1,054
1,766
1,233
2,300
1,712
1,848
1,8481,7122,3001,2331,7661,0541,2992,1311,7743,2731,5221,7612,3442,2081,9531,1835755498833,2081,4217938688015390
       Other Current Liabilities 
0
254
146
266
404
603
448
576
558
1,388
868
627
792
1,170
712
835
995
1,366
1,351
2,149
2,899
3,662
4,922
5,748
7,141
0
07,1415,7484,9223,6622,8992,1491,3511,3669958357121,1707926278681,3885585764486034042661462540
   > Long-term Liabilities 
0
0
603
1,016
1,577
1,421
119
86
52
4,559
4,570
4,789
6,788
6,862
6,432
6,064
5,586
5,277
6,331
5,992
5,678
5,491
5,193
4,619
4,241
22
224,2414,6195,1935,4915,6785,9926,3315,2775,5866,0646,4326,8626,7884,7894,5704,55952861191,4211,5771,01660300
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
4,540
4,570
4,587
6,496
6,532
6,183
5,856
0
0
0
0
5,678
5,384
5,107
0
0
0
0005,1075,3845,67800005,8566,1836,5326,4964,5874,5704,540000000000
       Warrants
0
0
0
0
21,161
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000021,1610000
       Other Liabilities 
0
520
603
1,016
1,577
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001,5771,0166035200
       Deferred Long Term Liability 
0
0
0
0
397
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000003970000
> Total Stockholder Equity
0
12,130
10,162
7,496
4,751
26,303
19,242
16,699
12,348
10,550
10,620
7,031
1,388
15,663
21,555
20,736
15,660
17,630
13,383
13,242
11,181
13,078
11,241
16,725
16,892
15,477
15,47716,89216,72511,24113,07811,18113,24213,38317,63015,66020,73621,55515,6631,3887,03110,62010,55012,34816,69919,24226,3034,7517,49610,16212,1300
   Common Stock
0
6
6
6
6
18
18
18
18
18
21
21
21
24
24
25
25
25
25
25
25
25
26
26
26
0
0262626252525252525252424212121181818181866660
   Retained Earnings Total Equity00-101,235-105,794-103,134-104,0460000-89,058-87,042-92,158-84,471-77,967-73,237-64,188-61,492-56,527-53,278-45,868-19,8060000
   Accumulated Other Comprehensive Income 0000000000000-605-519-432-345-259-173-84-62-21,161-20,432-19,71000
   Capital Surplus 
0
0
0
0
3,390
72,153
72,502
73,208
73,822
74,720
83,836
84,977
85,838
107,797
108,573
109,769
0
0
0
0
115,202
116,187
117,009
117,934
0
0
00117,934117,009116,187115,2020000109,769108,573107,79785,83884,97783,83674,72073,82273,20872,50272,1533,3900000
   Treasury Stock00000000000000000000000000
   Other Stockholders Equity 
0
0
22,519
23,657
24,551
72,153
72,502
73,208
73,822
74,720
83,836
84,977
85,838
107,797
108,573
109,769
110,787
111,718
112,801
114,218
115,202
116,187
117,009
117,934
118,680
0
0118,680117,934117,009116,187115,202114,218112,801111,718110,787109,769108,573107,79785,83884,97783,83674,72073,82273,20872,50272,15324,55123,65722,51900



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue31,642
Cost of Revenue-10,581
Gross Profit21,06121,061
 
Operating Income (+$)
Gross Profit21,061
Operating Expense-32,834
Operating Income-1,192-11,773
 
Operating Expense (+$)
Research Development3,322
Selling General Administrative18,931
Selling And Marketing Expenses0
Operating Expense32,83422,253
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-503
Net Interest Income503
 
Pretax Income (+$)
Operating Income-1,192
Net Interest Income503
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-689-1,192
EBIT - interestExpense = 0
-936
-936
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-689
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-689
Tax Provision-247
Net Income From Continuing Ops-936-936
Net Income-936
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-503
 

Technical Analysis of Eton Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Eton Pharmaceuticals Inc. The general trend of Eton Pharmaceuticals Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Eton Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Eton Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 3.33 < 3.39 < 3.97.

The bearish price targets are: 2.47 > 2.42 > 2.3601.

Tweet this
Eton Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Eton Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Eton Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Eton Pharmaceuticals Inc. The current macd is -0.21840848.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Eton Pharmaceuticals Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Eton Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Eton Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Eton Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartEton Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Eton Pharmaceuticals Inc. The current adx is 19.34.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Eton Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Eton Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Eton Pharmaceuticals Inc. The current sar is 3.53271014.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Eton Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Eton Pharmaceuticals Inc. The current rsi is 37.64. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Eton Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartEton Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Eton Pharmaceuticals Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Eton Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Eton Pharmaceuticals Inc Daily Stochastic Oscillator ChartEton Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Eton Pharmaceuticals Inc. The current cci is -50.20342574.

Eton Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartEton Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Eton Pharmaceuticals Inc. The current cmo is -18.75320988.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Eton Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartEton Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Eton Pharmaceuticals Inc. The current willr is -65.87962331.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Eton Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Eton Pharmaceuticals Inc Daily Williams %R ChartEton Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Eton Pharmaceuticals Inc. The current atr is 0.20384663.

Eton Pharmaceuticals Inc Daily Average True Range (ATR) ChartEton Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Eton Pharmaceuticals Inc. The current obv is 21,761,601.

Eton Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartEton Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Eton Pharmaceuticals Inc. The current mfi is 34.19.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Eton Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartEton Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Eton Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Eton Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Eton Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.644
Ma 20Greater thanMa 503.459
Ma 50Greater thanMa 1003.948
Ma 100Greater thanMa 2004.152
OpenGreater thanClose3.270
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Eton Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Eton Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Eton Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Eton Pharmaceuticals Inc

I send you an email if I find something interesting about Eton Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Eton Pharmaceuticals Inc.

Receive notifications about Eton Pharmaceuticals Inc in your mailbox!